MACQUARIE GROUP LTD - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 215 filers reported holding MYRIAD GENETICS INC in Q3 2021. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.

Quarter-by-quarter ownership
MACQUARIE GROUP LTD ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q3 2023$1,879,000
-30.0%
117,132
+1.1%
0.00%
-33.3%
Q2 2023$2,685,000
-14.4%
115,823
-14.2%
0.00%
-25.0%
Q1 2023$3,136,000
+60.1%
135,0000.0%0.00%
+100.0%
Q4 2022$1,959,000
-24.9%
135,000
-0.6%
0.00%
-33.3%
Q3 2022$2,607,000
+5.0%
135,784
-0.6%
0.00%0.0%
Q2 2022$2,482,000
-27.9%
136,6200.0%0.00%0.0%
Q1 2022$3,443,000
-8.7%
136,6200.0%0.00%0.0%
Q4 2021$3,771,000
-14.5%
136,6200.0%0.00%
-25.0%
Q3 2021$4,411,000
+5.6%
136,6200.0%0.00%
+33.3%
Q2 2021$4,178,000
-0.6%
136,620
-1.0%
0.00%
-50.0%
Q1 2021$4,203,000
+52.8%
138,023
-0.8%
0.01%
+50.0%
Q4 2020$2,751,000
+51.7%
139,0840.0%0.00%
+33.3%
Q3 2020$1,813,000
+15.0%
139,0840.0%0.00%0.0%
Q2 2020$1,577,000
-20.3%
139,084
+0.6%
0.00%
-25.0%
Q1 2020$1,979,000
-47.5%
138,3000.0%0.00%
-20.0%
Q4 2019$3,766,000
-7.2%
138,300
-2.4%
0.01%
-28.6%
Q3 2019$4,057,000
-66.9%
141,700
-67.9%
0.01%0.0%
Q2 2019$12,249,000
+173.3%
441,000
+226.7%
0.01%
-12.5%
Q1 2019$4,482,000
+14.2%
135,0000.0%0.01%0.0%
Q4 2018$3,924,000
-36.9%
135,000
-0.1%
0.01%
-20.0%
Q3 2018$6,219,000
+19.6%
135,200
-2.8%
0.01%
+11.1%
Q2 2018$5,198,000
+20.4%
139,100
-4.8%
0.01%
+12.5%
Q1 2018$4,317,000
-13.6%
146,100
+0.4%
0.01%
-11.1%
Q4 2017$4,998,000
+2.3%
145,500
+7.8%
0.01%0.0%
Q3 2017$4,884,000
+40.0%
135,0000.0%0.01%
+50.0%
Q2 2017$3,488,000
+34.6%
135,0000.0%0.01%
+20.0%
Q1 2017$2,592,000
+15.2%
135,0000.0%0.01%
+25.0%
Q4 2016$2,250,000
+68.2%
135,000
+107.7%
0.00%
+33.3%
Q3 2016$1,338,000
-66.4%
65,000
-50.0%
0.00%
-25.0%
Q2 2016$3,978,000
+63.5%
130,000
+100.0%
0.00%
-20.0%
Q1 2016$2,433,000
-68.1%
65,000
-63.2%
0.01%
-68.8%
Q4 2015$7,618,000
+10.8%
176,500
-3.8%
0.02%
+6.7%
Q3 2015$6,874,000
+12.1%
183,400
+1.7%
0.02%
+25.0%
Q2 2015$6,132,000
-4.0%
180,4000.0%0.01%
-7.7%
Q1 2015$6,386,000
-11.7%
180,400
-15.1%
0.01%
-13.3%
Q4 2014$7,234,000
-10.4%
212,400
+1.4%
0.02%
-11.8%
Q3 2014$8,077,000
+0.1%
209,400
+1.0%
0.02%
-5.6%
Q2 2014$8,072,000
+12.8%
207,400
-1.0%
0.02%
+50.0%
Q1 2014$7,159,000
+65.3%
209,400
+1.5%
0.01%
+50.0%
Q4 2013$4,330,000
+130.3%
206,400
+158.0%
0.01%
+100.0%
Q3 2013$1,880,000
+598.9%
80,000
+700.0%
0.00%
+300.0%
Q2 2013$269,00010,0000.00%
Other shareholders
MYRIAD GENETICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
SCOPIA CAPITAL MANAGEMENT LP 5,809,799$205,667,0004.45%
Tieton Capital Management, LLC 146,650$5,191,0003.90%
KESTREL INVESTMENT MANAGEMENT CORP 614,275$21,745,0002.97%
Provident Investment Management, Inc. 375,032$13,276,0002.70%
Summit Street Capital Management, LLC 77,810$2,754,0002.46%
RATIONAL ADVISORS LLC 253,200$8,963,0002.17%
S&T BANK/PA 393,446$13,928,0002.08%
Euclidean Technologies Management, LLC 63,684$2,254,0002.05%
Grace Capital 220,769$7,815,0001.76%
AIMZ Investment Advisors, LLC 57,850$2,048,0001.75%
View complete list of MYRIAD GENETICS INC shareholders